Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
ASCEPT was founded in 1966, and held its first scientific meeting a year later. Since that time, ASCEPT has developed into the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australasia.
THINKING OF JOINING?
We promote advances in research, provide teaching & training and ensure that ASCEPT has a major role in advising government and other organisations on related matters. You can also benefit from discounted rates and networking opportunities.
SPECIAL INTEREST GROUPS
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context.
ASCEPT recent articles and events
Latest News
Twitter Feed
National Medication Safety Symposium
We are very pleased to invite you to attend the National Medication Safety Symposium on 21 September 2022 at …
19th World Congress of Basic & Clinical Pharmacology 2023
2 – 7 July 2023, Glasgow, Scotland. In 2023, the global pharmacology and therapeutics community will unite …
Call for symposia proposals
Submission is now open for symposia proposals to be presented at the APSA-ASCEPT 2022 Joint Conference to …
Twitter Feed
NEW: #Paxlovid prescribing guide
We've developed this guide in collaboration with @VicGovDH, to help GPs determine Paxlovid's suitability for adults with #mildCOVID19, & to navigate the complexities of the contraindications.
@RACGP @ACRRM @NPSMedicineWise
https://bit.ly/3dxTDU3
NEW AP ARTICLE
The anticholinergic burden refers to the cumulative effects of taking several drugs with anticholinergic actions. https://bit.ly/3vvr9k5
Prof Sarah Hilmer @DanijelaGnjidic @ASCEPTanz @Sydney_Uni Faculty of Medicine and Health
Modern antiretroviral therapy is usually well tolerated, but it is important to be aware of drug interactions which may reduce its effectiveness or cause toxicity. https://bit.ly/3M10AZf
Don't forget to submit your abstract by Monday to be selected for a short talk. @ASCEPTanz @MIPS_Australia https://twitter.com/DrEmGPCRologist/status/1547778806915952640
The annual Drug Discovery SIG ECR and HDR symposium is on again this year. Featuring presenattions from Yuliana Yosaatmadja and @mgotsbacher. Submit your abstracts by 1st August 2022 for a chance to be selected to give a short talk. Registration is free.
Are you a science superstar 💫? Get your application in for @ScienceAU’s game-changing, life-changing #SuperstarsofSTEM program to advance gender equity in STEM. Applications close 14 August. https://scienceandtechnologyaustralia.org.au/what-we-do/superstars-of-stem/
Special Interest Groups
Supporting Member Collaboration
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context. Currently, there are SIGs in the following areas.
Cardiovascular
The Cardiovascular SIG (formed in 2008) aims to foster collaboration and exchange of ideas across all areas of cardiovascular research.
Click here
Clinical Pharmacology
Clinical Pharmacology involves all aspects of safe, effective and rational use of medicines in humans (individual, group, or population levels).
Click here
Drug Discovery
This forum provides an opportunity for the exchange of ideas and sharing of issues of concern. Please use it to ask questions, highlight initiatives or events, or propose ideas for future Forum events.
Click here
Drug Disposition and Response
Drug Disposition and Response involves the distribution, metabolism and excretion of drug and the relationship between drug concentrations and effects..
Click here
Education Forum
A conduit for the sharing of ideas and resources between those involved in pharmacology education, with the overall aim of ensuring that all students of pharmacology receive a quality education that prepares them for their future careers.
Click here
Gastrointestinal-urogenital
The Urogenital/Gastrointestinal SIG promotes research in the field of urogenital and gastrointestinal pharmacology and disseminate findings to Australian researchers while encouraging early career researchers with opportunities to present their work.
Click here
Innovation and Industry
The Innovation and Industry SIG is open to all experimental through to clinical pharmacologists and toxicologists, as well as those from industry in its broadest sense, who have an interest and/or role in moving innovations along the pathway towards generating medical products or services to benefit patients.
Click here
Neuropharmacology
The Neuropharmacology and behavioural SIG is interested in how drugs affect cellular activity within the nervous system and how this influences behaviour.
Click here
New Zealand Forum
To provide an annual forum to promote and disseminate pharmacology & toxicology research, clinical practice and education within New Zealand and beyond.
Click here
Pharmacoepidemiology
The role of the Pharmacoepidemiology SIG is to promote and support pharmacoepidemiological research and collaboration within ASCEPT members.
Click here
Pharmacogenomics
The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.
Click here
Respiratory and Inflammation
The Respiratory & Inflammation SIG aims to facilitate cutting edge research in the areas of respiratory and inflammatory diseases.
Click here
Toxicology
Open to all who have an interest in toxicology. Including but not limited to drugs, medicines and consumer product toxicity, pesticides and agrichemicals, nanomaterials, occupational chemicals and industrial pollutants, naturally occurring toxic chemicals and poisons, poisoning management and clinical toxicity.
Click here
Partners and Sponsors
